✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (247 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
37.46
4,08,847
64.69
1,60,745
63.71
1,36,346
23.55
1,07,075
18.59
1,03,507
23.19
1,00,286
18.51
91,069
48.48
86,264
20.56
70,376
28.59
67,502
123
59,755
38.19
57,624
51.88
55,256
62.78
52,941
42.67
40,762
43.00
35,762
34.80
35,308
75.28
33,969
36.67
31,070
40.32
30,393
33.46
29,103
-
22,956
108
21,689
25.82
21,672
-
21,600
47.57
19,771
72.25
17,350
59.67
17,090
56.73
16,281
24.74
15,696
32.35
15,455
42.50
15,386
9.80
15,073
24.65
14,516
25.92
14,142
56.61
14,031
694
13,967
94.53
12,701
38.14
12,355
26.29
11,541
21.20
11,526
51.06
10,570
45.46
9,905
226
9,464
22.49
9,297
60.45
9,033
28.39
8,710
22.78
8,012
15.66
8,008
20.32
7,159
29.60
7,097
22.33
7,079
48.71
6,755
27.85
6,279
44.50
6,108
30.33
5,531
-
4,603
-
4,500
30.99
4,103
-
3,962
37.17
3,777
75.33
3,638
68.06
3,557
16.68
3,379
27.86
3,310
21.43
3,263
16.04
3,250
54.82
3,120
35.70
3,011
33.24
2,940
403
2,585
7.64
2,474
239
2,419
-
2,333
19.60
2,270
21.78
2,148
-
2,081
17.82
1,954
32.26
1,836
26.77
1,802
57.83
1,686
34.67
1,471
22.61
1,358
38.51
1,352
20.95
1,321
31.75
1,300
25.25
1,239
45.44
1,182
28.33
1,159
21.45
1,122
13.42
1,024
3.92
975
8.66
970
11.71
937
46.75
912
20.92
899
44.68
882
43.36
870
21.20
821
24.18
799
-
786
33.37
685
40.24
666
-
645
22.36
617
32.55
589
27.97
549
38.43
514
31.68
505
45.08
483
14.39
466
39.94
419
60.95
403
35.19
399
-
394
47.77
384
20.29
379
30.01
363
53.50
352
29.48
346
67.01
329
64.13
325
17.81
303
-
298
30.71
294
32.32
284
84.00
278
25.32
269
-
266
-
255
28.59
234
23.58
231
-
226
33.70
224
22.00
214
28.43
212
20.90
201
40.04
182
15.64
180
49.88
179
56.83
176
-
172
660
171
12.22
166
30.25
162
9.17
159
149
158
15.75
151
-
148
7.95
148
11.82
145
12.89
142
52.98
138
28.68
134
16.29
131
28.34
128
5.20
126
16.23
125
-
122
16.34
112
11.50
111
22.80
109
187
108
14.83
106
-
104
27.04
101
19.27
95
-
89
29.63
88
14.09
86
11.90
85
11.98
81
179
76
-
75
6.71
72
9.67
70
59.06
70
15.75
68
18.45
68
13.54
67
43.02
67
23.57
67
-
66
15.72
64
82.32
64
-
62
90.04
57
-
57
13.20
56
3.63
55
15.61
52
22.60
52
-
50
218
49
-
48
237
48
-
45
18.38
43
95.31
42
55.32
41
19.46
38
79.08
36
-
35
7.22
35
23.74
34
16.81
33
21.10
33
-
33
7.82
32
37.12
32
-
32
14.67
30
215
30
8.55
29
7.26
29
-
28
12.07
26
65.60
22
21.77
21
27.71
18
-
18
-
17
35.13
17
54.70
16
59.17
14
14.01
14
-
14
-
13
-
12
-
11
48.22
11
9.70
10
-
10
-
9
-
9
53.26
8
-
8
-
7
89.76
7
-
5
37.05
5
560
5
-
5
-
3
47.33
3
-
2
-
1
Showing 5 247 of 247 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material